John Valliant

Companies

• Fusion PharmaceuticalsBoard member Jun 25, 2020 to Jun 4, 2024¹
• Fusion PharmaceuticalsChief executive officer Jun 25, 2020 to Jun 4, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Fusion Pharmaceuticals FUSN0 shares²Jun 4, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 4, 2024Returned to company 318,147 shares of Fusion Pharmaceuticals²
• Apr 27, 2022Sold 4,511 shares at $6.03 of Fusion Pharmaceuticals³
• Apr 26, 2022Sold 2,147 shares at $6.07 of Fusion Pharmaceuticals³
• Apr 25, 2022Sold 2,036 shares at $6.03 of Fusion Pharmaceuticals³
• Apr 21, 2022Sold 922 shares at $6.01 of Fusion Pharmaceuticals⁴
• Apr 20, 2022Sold 367 shares at $6.02 of Fusion Pharmaceuticals⁴
• Apr 13, 2022Sold 11,994 shares at $6.41 of Fusion Pharmaceuticals⁵
• Apr 12, 2022Sold 18,255 shares at $7.10 of Fusion Pharmaceuticals⁵
• Apr 11, 2022Sold 2,600 shares at $7.37 of Fusion Pharmaceuticals⁵
• Apr 8, 2022Sold 826 shares at $7.52 of Fusion Pharmaceuticals⁶
• Apr 7, 2022Sold 1,255 shares at $7.56 of Fusion Pharmaceuticals⁶
• Apr 6, 2022Sold 100 shares at $7.58 of Fusion Pharmaceuticals⁶
• Apr 5, 2022Sold 2,100 shares at $7.67 of Fusion Pharmaceuticals⁷
• Apr 4, 2022Sold 700 shares at $7.81 of Fusion Pharmaceuticals⁷
• Apr 1, 2022Sold 1,000 shares at $7.75 of Fusion Pharmaceuticals⁷
• Mar 30, 2022Sold 300 shares at $7.52 of Fusion Pharmaceuticals⁸
• Mar 29, 2022Sold 200 shares at $7.52 of Fusion Pharmaceuticals⁹
• Mar 28, 2022Sold 9,600 shares at $7.55 of Fusion Pharmaceuticals⁹
• Mar 25, 2022Sold 500 shares at $7.42 of Fusion Pharmaceuticals⁹
• Mar 23, 2022Sold 100 shares at $7.50 of Fusion Pharmaceuticals¹⁰
• Mar 22, 2022Sold 4,000 shares at $7.53 of Fusion Pharmaceuticals¹⁰
• Mar 21, 2022Sold 700 shares at $7.46 of Fusion Pharmaceuticals¹⁰
• Mar 21, 2022Sold 1,500 shares at $7.47 of Fusion Pharmaceuticals¹¹
• Mar 18, 2022Sold 1,204 shares at $7.61 of Fusion Pharmaceuticals¹¹
• Mar 17, 2022Sold 900 shares at $7.51 of Fusion Pharmaceuticals¹¹